Sljedeći

Auto Play

CAR T-Cell Therapy for Relapsed/Refractory CLL

2 Pogledi • 07/14/23
Udio
Ugraditi
administrator
administrator
Pretplatnici
0

The panelists provide insight on the use of chimeric antigen receptor T-cell therapy for chronic lymphocytic leukemia and the TRANSCEND CLL-004 trial of liso-cel (JCAR017) in relapsed/refractory disease.

Prikaži više
0 Komentari sort Poredaj po
Komentari na Facebooku

Sljedeći

Auto Play